LMAT - LeMaitre Vascular, Inc. -  [ ]

Ticker Details
LeMaitre Vascular, Inc.
LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
IPO Date: October 19, 2006
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $2.23B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.46 | 1.86%
Avg Daily Range (30 D): $1.83 | 1.68%
Avg Daily Range (90 D): $1.52 | 1.49%
Institutional Daily Volume
Avg Daily Volume: .07M
Avg Daily Volume (30 D): .18M
Avg Daily Volume (90 D): .16M
Trade Size
Avg Trade Size (Sh.): 62
Avg Trade Size (Sh.) (30 D): 35
Avg Trade Size (Sh.) (90 D): 35
Institutional Trades
Total Institutional Trades: 1,765
Avg Institutional Trade: $1.71M
Avg Institutional Trade (30 D): $2.89M
Avg Institutional Trade (90 D): $2.83M
Avg Institutional Trade Volume: .03M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.78M
Avg Closing Trade (30 D): $3.07M
Avg Closing Trade (90 D): $3.32M
Avg Closing Volume: 27.54K
 
News
May 5, 2026 @ 8:05 PM
LeMaitre Q1 2026 Financial Results
Source: Na
Mar 28, 2026 @ 12:06 AM
LeMaitre Vascular Up 30% as Insider Sells $285K in...
Source: Jonathan Ponciano
Feb 27, 2026 @ 7:50 PM
LeMaitre to Participate at Upcoming Investor Confe...
Source: Na
Oct 9, 2025 @ 9:53 PM
LeMaitre Will Announce Third Quarter 2025 Earnings...
Source: Lemaitre Vascular, Inc.
Aug 6, 2025 @ 5:09 AM
LeMaitre (LMAT) Q2 Revenue Jumps 15%
Source: Jesterai
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $2.76 $.69 $.69
Diluted EPS $2.71 $.68 $.68
Revenue $256.28M $66.55M $64.45M
Gross Profit $185.52M $48.4M $46.19M
Net Income / Loss $62.4M $15.68M $15.58M
Operating Income / Loss $73.06M $17.78M $18.83M
Cost of Revenue $70.77M $18.16M $18.26M
Net Cash Flow $1.04M $-1.25M $2.75M
PE Ratio